Advertisement
x
Business
Practice ManagementMalpractice ConsultHealth Law & Policy
Media
Case-Based Peer PerspectivesInvestigator Perspectives Medical World NewsPodcastsUrology Medical PerspectivesUTv VideosPeer ExchangeSpecial ReportVirtual Tumor BoardInsightsMedcastPeers & Perspectives
Conferences
Conference ListingConference Previews Conference Recaps
Publications
Urology Times JournalEditorial Advisory BoardUrologists in Cancer CareSupplements and Featured PublicationsClinical Forums Recaps
More
CME/CE
Resources
Begin Your Journey: Tackling BurnoutSponsored MediaLive EventsInteractive ToolsJob BoardPartnersSponsored ResourcesTreatment Landscape Evolutions

Subscribe

  • Business
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Benign Conditions
  • Benign Prostatic Hyperplasia
  • Bladder Cancer
  • Female Urology
  • Genitourinary Cancers
  • Genomic Testing
  • Hormone Therapy
  • Kidney Cancer
  • Kidney Stones
    • Challenging Anatomy
  • Men's Health
  • Next-Generation Imaging
  • OAB and Incontinence
    • Voiding Dysfunction
  • Pediatrics
  • Prostate Cancer
    • Controveries in Urologic Cancer
    • Drug Therapy
  • Sexual Dysfunction
  • UTUC
  • Urologic Surgery
    • Cosmetic Surgery
Spotlight -
Peer Exchange|
Peers and Perspectives|
Case-Based Peer Perspectives|
Urology Times Journal
Advertisement

Austin Lee

  1. Home
  2. /
  3. authors
  4. /
  5. austin-lee
Advertisement

Articles by Austin Lee

sashafolly - stock.adobe.com

Bicycle riding: Good or bad for men’s health?

ByAustin Lee,Benjamin N. Breyer, MD, MAS
March 11th 2020

Cycling has multiple benefits, and steps can be taken to prevent genitourinary injury.

Advertisement

Latest Updated Articles

  • sashafolly - stock.adobe.com
    Bicycle riding: Good or bad for men’s health?

    Published: March 11th 2020 | Updated:



Advertisement
Advertisement

Trending on Urology Times

1

The UroOnc Minute: Active Surveillance for Intermediate-risk Prostate Cancer, with Michael Leapman, MD, MHS

2

Christof Vulsteke, MD, PhD, breaks down findings, implications of KEYNOTE-905

3

The Significance of KEYNOTE-905 in Muscle-Invasive Bladder Cancer

4

Petros Grivas, MD, on the significance of a perioperative regimen for cisplatin-ineligible MIBC

5

Chemoablation reshapes nonsurgical care in recurrent NMIBC

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Job Board
  • Terms and Conditions
  • Privacy
  • Do not sell my Personnal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us